title: Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis.
abstract: In a series of transgenic mice, the human tissue collagenase gene was expressed in the suprabasal layer of the skin epidermis. Visually, the mice had dry and scaly skin which upon histological analysis revealed acanthosis, hyperkeratosis, and epidermal hyperplasia. At the ultrastructural level, intercellular granular materials were absent in the transgenic skin epidermis but contact was maintained through the intact desmosomes. Despite a diversity of underlying etiologies, similar morphological hyperproliferative changes in the epidermis are observed in the human skin diseases of lamellar ichthyosis, atopic dermatitis, and psoriasis. Subsequent experiments demonstrate that when the transgenic mouse skin was treated once with an initiator (7,12-dimethyl-benz[a]anthracene) and then twice weekly with a promoter (12-O-tetradecanoylphorbol-13-acetate), there was a marked increase in tumor incidence among transgenic mice compared with that among control littermates. These experiments demonstrate that by overexpressing the highly specific proteolytic enzyme collagenase, a cascade of events leading to profound morphological changes which augment the sensitivity of the skin towards carcinogenesis is initiated in the epidermis.
authors.affiliation: Department of Biochemistry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
authors.forename: J
authors.initials: J
authors.lastname: D'Armiento
authors.forename: T
authors.initials: T
authors.lastname: DiColandrea
authors.forename: S S
authors.initials: SS
authors.lastname: Dalal
authors.forename: Y
authors.initials: Y
authors.lastname: Okada
authors.forename: M T
authors.initials: MT
authors.lastname: Huang
authors.forename: A H
authors.initials: AH
authors.lastname: Conney
authors.forename: K
authors.initials: K
authors.lastname: Chada
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology; D000052:Acanthosis Nigricans / Q000201:enzymology*; D000818:Animals; D015197:Carcinogenicity Tests; D017364:Collagenases / Q000096:biosynthesis* / Q000502:physiology; D004198:Disease Susceptibility; D004817:Epidermis / Q000648:ultrastructure; D006242:Haptoglobins / Q000235:genetics; D006801:Humans; D006965:Hyperplasia; D007642:Keratosis / Q000201:enzymology*; D051379:Mice; D008822:Mice, Transgenic; D010212:Papilloma / Q000473:pathology; D011401:Promoter Regions, Genetic / Q000235:genetics; D012867:Skin / Q000187:drug effects / Q000201:enzymology*; D012878:Skin Neoplasms / Q000209:etiology* / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D006242:Haptoglobins; D015127:9,10-Dimethyl-1,2-benzanthracene; D017364:Collagenases; D013755:Tetradecanoylphorbol Acetate